VYNE Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
VYNE Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2024.
  • VYNE Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 42.6M shares, a 315% increase year-over-year.
  • VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 42.6M shares, a 315% increase from 2023.
  • VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10.3M shares, a 222% increase from 2022.
  • VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.19M shares, a 11.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 42.6M +32.3M +315% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 10.3M +7.09M +222% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 3.19M +327K +11.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 2.86M -29.6M -91.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 32.4M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.